These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18926279)

  • 21. Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants.
    Kelley KF; Caudwell E; Xueref S; Ha TH; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4():S250-3. PubMed ID: 22544183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global Development Assistance for Adolescent Health From 2003 to 2015.
    Li Z; Li M; Patton GC; Lu C
    JAMA Netw Open; 2018 Aug; 1(4):e181072. PubMed ID: 30646101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Funding allocation to surgery in low and middle-income countries: a retrospective analysis of contributions from the USA.
    Gutnik L; Dieleman J; Dare AJ; Ramos MS; Riviello R; Meara JG; Yamey G; Shrime MG
    BMJ Open; 2015 Nov; 5(11):e008780. PubMed ID: 26553831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Civil society organisations and global health initiatives: problems of legitimacy.
    Doyle C; Patel P
    Soc Sci Med; 2008 May; 66(9):1928-38. PubMed ID: 18291566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Government funding is up; private donations are down.
    AIDS Alert; 1999 Dec; 14(12):141-4. PubMed ID: 11366991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.
    Sulzbach S; De S; Wang W
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing performance of Global Fund-supported tuberculosis grants.
    Katz I; Aziz MA; Olszak-Olszewski M; Komatsu R; Low-Beer D; Atun R
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1097-103. PubMed ID: 20819253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sources and Focus of Health Development Assistance, 1990-2014.
    Dieleman JL; Graves C; Johnson E; Templin T; Birger M; Hamavid H; Freeman M; Leach-Kemon K; Singh L; Haakenstad A; Murray CJ
    JAMA; 2015 Jun; 313(23):2359-68. PubMed ID: 26080340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Clinton C; Sridhar D
    Lancet; 2017 Jul; 390(10091):324-332. PubMed ID: 28139255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.
    Kovacs SD; Mills BM; Stergachis A
    Malar J; 2017 Jul; 16(1):282. PubMed ID: 28693488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
    Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
    Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Global Fund Round 11 cancellation fiasco: turning disaster into opportunity?
    Zumla A
    Int J Tuberc Lung Dis; 2012; 16(3):285-6. PubMed ID: 22640440
    [No Abstract]   [Full Text] [Related]  

  • 34. Gates donates $750m, but Global Fund still needs more backers.
    Gulland A
    BMJ; 2012 Jan; 344():e711. PubMed ID: 22286594
    [No Abstract]   [Full Text] [Related]  

  • 35. The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries.
    Leach-Kemon K; Chou DP; Schneider MT; Tardif A; Dieleman JL; Brooks BP; Hanlon M; Murray CJ
    Health Aff (Millwood); 2012 Jan; 31(1):228-35. PubMed ID: 22174301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [International financing for cooperation to develop health in Latin America and the Caribbean].
    De Los Ríos R; Arósquipa C; Vigil-Oliver W
    Rev Panam Salud Publica; 2011 Aug; 30(2):133-43. PubMed ID: 22159722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investing to end epidemics: the role of the Global Fund to control TB by 2030.
    Kunii O; Yassin MA; Wandwalo E
    Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):153-4. PubMed ID: 26884492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
    Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
    Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does earmarked donor funding make it more or less likely that developing countries will allocate their resources towards programmes that yield the greatest health benefits?
    Waddington C
    Bull World Health Organ; 2004 Sep; 82(9):703-6; discussion 706-8. PubMed ID: 15628209
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.